SUMMARY: RATIONALITY IN USING PROTON PUMP DRUGS (PPI)

, ,

Main Article Content

Abstract

Objective: To investigate the reasonableness of using proton pump inhibitors (PPI) at 120 Military Hospital in Tien Giang province. Subjects and methods: Cross-sectional descriptive study on 4532 outpatient prescriptions of patients who were prescribed drugs by doctors from July 1st, 2020 to July 30th, 2020 at clinics of the examination department - Military Hospital 120. Results: Prescribing unsafe proton pump inhibitors accounted for 12.13%. Percentage of prescriptions without instructions for use of proton pump inhibitors (0.79%). The proportion of prescription drugs with drug interactions was 52.14%, clopidogrel was the most interactive drug commonly used with PPIs (48.3%). The proportion of proton pump inhibitors indicated unreasonable was 9.76%. The proportion of prescriptions with proton pump inhibitors for gastritis treatment accounted for 66.14% of the total number of prescriptions with proton pump inhibitors that were not reasonable. Conclusion: The proportion of proton pump inhibitors was not safe and reasonable and the proportion of prescription drugs with no instructions on how long to use proton pump inhibitors were low. The proportion of prescription interacting drugs accounted for a high  proportion, clopidogrel was the most interactive drug commonly used with PPIs. Unreasonable prescriptions in PPI used mainly gastritis.

Article Details

References

1. MinerP Jr, Katz PO, Chen Y et al (2003). Gastric acid control with esomeprazole, lansoprazole omeprazole, pantoprazole and rabeprazole: a-five-waycrossover study. Am J Gastroenterol, 98(12): 2616-20.
2. Mai Nguyệt Ánh (2011). So sánh hiệu quả điều trị viêm loét DD-TT do nhiễm HP giữa hai phác đồ PAL và PAC tại Bệnh viện ĐK Đồng Nai.
3. Lê Diễn Đức (2016), Đánh giá việc sử dụng nhóm thuốc ức chế bơm proton trong dự phòng loét tiêu hóa do stress tại một bệnh viện tuyến trung ương - giai đoạn 2010-2014, Luận văn thạc sĩ y học.
4. Bùi Hữu Hoàng (2011). Hiệu quả của phác đồ nối tiếp trong điều trị tiệt trừ Helicobacter pilori ở bệnh nhân viêm loét dạ dày tá tràng. Tạp chí Y học TP Hồ Chí Minh, 15: 303-307.
5. www.medscape.com/druginfo/druginterchecker.
6. www.fda.gov/drugs/drugsafety/.
7. Ahmed Yacoob Mayet (2007). Improper use of antisecretory drugs in a tertiary care teaching hospital: An observational study. The Saudi Journal of Gastroenterology, 13(3): 124-128.